Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Other Non-Current Liabilities: 2011-2012

Historic Other Non-Current Liabilities for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Sep 2012 value amounting to $2.0 million.

  • Sonoma Pharmaceuticals' Other Non-Current Liabilities rose 8.46% to $2.0 million in Q3 2012 from the same period last year, while for Sep 2012 it was $2.0 million, marking a year-over-year increase of 8.46%. This contributed to the annual value of $2.0 million for FY2012, which is 166.67% up from last year.
  • As of Q3 2012, Sonoma Pharmaceuticals' Other Non-Current Liabilities stood at $2.0 million, which was down 0.00% from $2.0 million recorded in Q2 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Other Non-Current Liabilities ranged from a high of $2.0 million in Q4 2011 and a low of $750,000 during Q1 2011.
  • For the 2-year period, Sonoma Pharmaceuticals' Other Non-Current Liabilities averaged around $1.8 million, with its median value being $2.0 million (2012).
  • Data for Sonoma Pharmaceuticals' Other Non-Current Liabilities shows a peak YoY soared of 166.67% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Other Non-Current Liabilities (Quarterly) stood at $2.0 million in 2011, then climbed by 8.46% to $2.0 million in 2012.
  • Its Other Non-Current Liabilities stands at $2.0 million for Q3 2012, versus $2.0 million for Q2 2012 and $2.0 million for Q1 2012.